Sushmita D. Lahiri
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Enzyme Structure and Function, Cancer therapeutics and mechanisms
Most-Cited Works
- → Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases(2013)350 cited
- → The Pentacovalent Phosphorus Intermediate of a Phosphoryl Transfer Reaction(2003)325 cited
- → ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii(2017)267 cited
- → Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases(2013)219 cited
- → Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3(2015)176 cited
- → The 2.1 Å Structure of Torpedo californica Creatine Kinase Complexed with the ADP-Mg2+−NO3-−Creatine Transition-State Analogue Complex,(2002)137 cited
- → Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC(2015)125 cited
- → Caught in the Act: The Structure of Phosphorylated β-Phosphoglucomutase from Lactococcus lactis,(2002)113 cited
- → Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48(2014)100 cited
- → Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases(2015)100 cited